Regulation of nuclear transport in disease

疾病中核转运的调节

基本信息

  • 批准号:
    8664768
  • 负责人:
  • 金额:
    $ 32.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-01 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mutations in structural components of the nuclear lamina cause a spectrum of human diseases known as laminopathies. Specific mechanisms for how disruption of the lamina generates cellular phenotypes have not been elucidated. This proposal tests a new hypothesis for how mutation of the gene encoding lamin A gives rise to cellular phenotypes in the premature aging disease, Hutchinson-Gilford Progeria Syndrome (HGPS). The proposal is based on data showing (i) the nucleocytoplasmic Ran gradient is disrupted in HGPS patient cells and this can be recapitulated in naive cells; (ii) Ran gradient disruption causes mis-localization of the SUMOylation enzyme Ubc9 from the nucleus to the cytoplasm; (iii) Reducing the levels of reactive oxygen species, which are elevated in HGPS cells, restores nuclear localization of the RanGTPase and Ubc9. The overall hypothesis is that constitutive anchoring of pre-lamin A to the nuclear membrane generates reactive oxygen species that inhibit the Ran GTPase System, disrupt the Ran gradient, relocalize Ubc9 to the cytoplasm, and induce cellular phenotypes in Progeria. Thus, defects in the nuclear lamina are transduced into cellular phenotypes, at least in part, via changes in the nuclear transport machinery. In Aim 1 we will determine the source and mechanism of reactive oxygen species induction by Progerin. In Aim 2 we test the hypothesis that the Ran GTPase System acts as a sensor for pre-lamin A- induced oxidative stress. In Aim 3 we test the hypothesis that the SUMO conjugating enzyme Ubc9 functions as an effector of oxidative stress by responding to the Ran gradient and modulating gene expression. Our studies bring a new perspective to the Progeria field, which includes a signaling and nuclear transport-based based framework to help understand how disease phenotypes are generated at the cellular level.
描述(由申请人提供):核纤层结构成分的突变会导致一系列称为核纤层病的人类疾病。椎板破坏如何产生细胞表型的具体机制尚未阐明。该提案测试了一个新假设,即编码核纤层蛋白 A 的基因突变如何引起早衰疾病哈钦森-吉尔福德早衰综合症 (HGPS) 的细胞表型。该提议基于的数据显示:(i) HGPS 患者细胞中的核细胞质 Ran 梯度被破坏,这可以在初始细胞中重现; (ii) Ran梯度破坏导致SUMO化酶Ubc9从细胞核错误定位到细胞质; (iii) 降低 HGPS 细胞中升高的活性氧水平,恢复 RanGTPase 和 Ubc9 的核定位。总体假设是,核纤层蛋白前体 A 与核膜的组成性锚定会产生活性氧,从而抑制 Ran GTPase 系统,破坏 Ran 梯度,将 Ubc9 重新定位到细胞质,并诱导早衰症的细胞表型。因此,核纤层中的缺陷至少部分地通过核运输机制的变化转变成细胞表型。在目标 1 中,我们将确定 Progerin 诱导活性氧的来源和机制。在目标 2 中,我们测试了 Ran GTPase 系统作为前核纤层蛋白 A 诱导的氧化应激传感器的假设。在目标 3 中,我们测试了这样的假设:SUMO 结合酶 Ubc9 通过响应 Ran 梯度和调节基因表达而发挥氧化应激效应子的作用。我们的研究为早衰症领域带来了新的视角,其中包括基于信号传导和核运输的框架,以帮助了解疾病表型是如何在细胞水平上产生的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bryce Paschal其他文献

Bryce Paschal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bryce Paschal', 18)}}的其他基金

Training in Cell and Molecular Biology
细胞和分子生物学培训
  • 批准号:
    10427127
  • 财政年份:
    2021
  • 资助金额:
    $ 32.15万
  • 项目类别:
Training in Cell and Molecular Biology
细胞和分子生物学培训
  • 批准号:
    10631060
  • 财政年份:
    2021
  • 资助金额:
    $ 32.15万
  • 项目类别:
Parp Function in Prostate Cancer
Parp 在前列腺癌中的功能
  • 批准号:
    10091413
  • 财政年份:
    2017
  • 资助金额:
    $ 32.15万
  • 项目类别:
Parp Function in Prostate Cancer
Parp 在前列腺癌中的功能
  • 批准号:
    9285034
  • 财政年份:
    2017
  • 资助金额:
    $ 32.15万
  • 项目类别:
Parp Function in Prostate Cancer
Parp 在前列腺癌中的功能
  • 批准号:
    10582213
  • 财政年份:
    2017
  • 资助金额:
    $ 32.15万
  • 项目类别:
Regulation of nuclear transport in disease
疾病中核转运的调节
  • 批准号:
    9036926
  • 财政年份:
    2012
  • 资助金额:
    $ 32.15万
  • 项目类别:
Regulation of nuclear transport in disease
疾病中核转运的调节
  • 批准号:
    8829120
  • 财政年份:
    2012
  • 资助金额:
    $ 32.15万
  • 项目类别:
Regulation of nuclear transport in disease
疾病中核转运的调节
  • 批准号:
    8448628
  • 财政年份:
    2012
  • 资助金额:
    $ 32.15万
  • 项目类别:
Regulation of nuclear transport in disease
疾病中核转运的调节
  • 批准号:
    8291575
  • 财政年份:
    2012
  • 资助金额:
    $ 32.15万
  • 项目类别:
Pathways of Nucleocytoplasmic Transport
核细胞质运输途径
  • 批准号:
    7935045
  • 财政年份:
    2009
  • 资助金额:
    $ 32.15万
  • 项目类别:

相似海外基金

Collaborative Research: Tools 4 Cells: Developing Next Generation Methods for Studying Cytoskeletal Factors in the Cell Nucleus
合作研究:工具 4 细胞:开发研究细胞核中细胞骨架因子的下一代方法
  • 批准号:
    2306188
  • 财政年份:
    2023
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Standard Grant
Evasion of antiviral responses in the host cell nucleus
逃避宿主细胞核中的抗病毒反应
  • 批准号:
    BB/X014126/1
  • 财政年份:
    2023
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Research Grant
Collaborative Research: Tools 4 Cells: Developing Next Generation Methods for Studying Cytoskeletal Factors in the Cell Nucleus
合作研究:工具 4 细胞:开发研究细胞核中细胞骨架因子的下一代方法
  • 批准号:
    2306187
  • 财政年份:
    2023
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Standard Grant
Direct Manipulation in Cell Nucleus
细胞核的直接操作
  • 批准号:
    22H01441
  • 财政年份:
    2022
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of pH-sensitive size reducible nanoparticles for cell nucleus target delivery in multidrug-resistant breast cancer
开发用于多重耐药乳腺癌细胞核靶向递送的 pH 敏感尺寸可缩减纳米颗粒
  • 批准号:
    22K12822
  • 财政年份:
    2022
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers
解剖感觉毛细胞核:开发一种研究小细胞中染色质相互作用(Tn5-Capture)的新方法
  • 批准号:
    10571130
  • 财政年份:
    2022
  • 资助金额:
    $ 32.15万
  • 项目类别:
Molecular Analysis of Nuclear Bodies and RNP Trafficking Pathways in the Cell Nucleus
细胞核中核体和 RNP 运输途径的分子分析
  • 批准号:
    BB/V010948/1
  • 财政年份:
    2021
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Research Grant
Exploration of the modification of genomic higher-order structures in the cell nucleus by aggregation of chemically synthesized short nucleic acids
通过化学合成的短核酸聚集修饰细胞核内基因组高阶结构的探索
  • 批准号:
    21K19040
  • 财政年份:
    2021
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
3D analysis of chromatin structure in cell nucleus with electron microscopy and mathematical modeling
利用电子显微镜和数学建模对细胞核染色质结构进行 3D 分析
  • 批准号:
    21K18234
  • 财政年份:
    2021
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Single particle dynamics of the NF-kB foci in the living cell nucleus
活细胞核中 NF-kB 焦点的单粒子动力学
  • 批准号:
    19K22404
  • 财政年份:
    2019
  • 资助金额:
    $ 32.15万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了